文献速递细菌感染、耐药与抗菌药物医院感染防控

头孢地尔:新型铁载体头孢菌素的发现、化学与体内特征

Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin.
PubMed 文献 · Clin Infect Dis · 2019-01-01

本文综述了新型铁载体头孢菌素头孢地尔的发现与化学特性。其儿茶酚基团可螯合铁并经铁转运通道主动进入细菌周质,对丝氨酸酶和金属β-内酰胺酶(含KPC、OXA-48、NDM)稳定,体外抗菌活性与动物模型体内疗效相关。

要点

  • 头孢地尔通过铁载体机制主动转运入菌,可克服碳青霉烯耐药革兰阴性菌。
  • 对KPC、OXA-48、NDM等丝氨酸酶和金属β-内酰胺酶稳定。
  • 体外抗菌与杀菌活性与多种动物模型体内疗效相关。

核心结论

  • 头孢地尔是一种新型铁载体头孢菌素,靶向包括碳青霉烯耐药株在内的革兰阴性菌。
  • 其化学结构赋予对β-内酰胺酶水解的结构稳定性,并具备有前景的体外与体内抗菌活性。

研究设计与样本

  • 综述类文章,总结头孢地尔的发现、化学结构及近期研究中的关键微生物学和体内研究结果。

主要发现

  • 头孢地尔结构与头孢他啶和头孢吡肟相似,可耐受β-内酰胺酶水解。
  • C-3侧链添加儿茶酚基团可螯合铁并模拟天然铁载体分子。
  • 螯合铁后经特殊铁转运通道主动转运穿过细菌外膜至周质空间。
  • 对丝氨酸β-内酰胺酶和金属β-内酰胺酶(含KPC、OXA-48、NDM)均显示结构稳定性。
  • 体外抗菌与杀菌活性与多种动物模型中的体内疗效相关。

临床怎么用

  • 可关注头孢地尔作为碳青霉烯耐药革兰阴性菌感染潜在治疗选择的价值。

局限性

  • 本文为综述,未报告新的临床试验数据或具体疗效阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The emergence of antimicrobial resistance is a significant public health issue worldwide, particularly for healthcare-associated infections caused by carbapenem-resistant gram-negative pathogens. Cefiderocol is a novel siderophore cephalosporin targeting gram-negative bacteria, including strains with carbapenem resistance. The structural characteristics of cefiderocol show similarity to both ceftazidime and cefepime, which enable cefiderocol to withstand hydrolysis by β-lactamases. The unique chemical component is the addition of a catechol moiety on the C-3 side chain, which chelates iron and mimics naturally occurring siderophore molecules. Following the chelation of iron, cefiderocol is actively transported across the outer membrane of the bacterial cell to the periplasmic space via specialized iron transporter channels. Furthermore, cefiderocol has demonstrated structural stability against hydrolysis by both serine- and metallo-β-lactamases, including clinically relevant carbapenemases such as Klebsiella pneumoniae carbapenemase, oxacillin carbapenemase-48, and New Delhi metallo-β-lactamase. Cefiderocol has demonstrated promising in vitro antibacterial and bactericidal activity, which correlates with its in vivo efficacy in several animal models. This article reviews the discovery and chemistry of cefiderocol, as well as some of the key microbiological and in vivo findings on cefiderocol from recently conducted investigations.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sato T, Yamawaki K. Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin. Clin Infect Dis. 2019. PMID: 31724047. doi:10.1093/cid/ciz826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。